Cargando…

Screening for gene expression fluctuations reveals latency-promoting agents of HIV

Upon treatment removal, spontaneous reactivation of latently infected T cells remains a major barrier toward curing HIV. Therapies that reactivate and clear the latent reservoir are only partially effective, while latency-promoting agents (LPAs) used to suppress reactivation and stabilize latency ar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Yiyang, Bohn-Wippert, Kathrin, Pazerunas, Patrick J., Moy, Jennifer M., Singh, Harpal, Dar, Roy D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	National Academy of Sciences 2021
Materias:	Biological Sciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980449/ https://www.ncbi.nlm.nih.gov/pubmed/33836565 http://dx.doi.org/10.1073/pnas.2012191118

Ejemplares similares

A transient heritable memory regulates HIV reactivation from latency
por: Lu, Yiyang, et al.
Publicado: (2021)

Fine-tuning of noise in gene expression with nucleosome remodeling
por: Megaridis, Melina R., et al.
Publicado: (2018)

Correction for Lu et al., Screening for gene expression fluctuations reveals latency-promoting agents of HIV
Publicado: (2022)

Monitoring reactivation of latent HIV by label-free gradient light interference microscopy
por: Goswami, Neha, et al.
Publicado: (2021)

Cell Size-Based Decision-Making of a Viral Gene Circuit
por: Bohn-Wippert, Kathrin, et al.
Publicado: (2018)

Similarity in viral and host promoters couples viral reactivation with host cell migration
por: Bohn-Wippert, Kathrin, et al.
Publicado: (2017)

Anti-latency agents to purge HIV reservoirs
por: Moreno, Santiago
Publicado: (2012)

Identification of celastrol as a novel HIV-1 latency reversal agent by an image-based screen
por: Liu, Hongbing, et al.
Publicado: (2021)

NSC95397 is a Novel HIV Latency Reversing Agent
por: Nichols Doyle, Randilea, et al.
Publicado: (2023)

Fluctuations in Tat copy number when it counts the most: a possible mechanism to battle the HIV latency
por: Konkoli, Zoran, et al.
Publicado: (2013)

Novel Histone Deacetylase Inhibitors and HIV-1 Latency-Reversing Agents Identified by Large-Scale Virtual Screening
por: Divsalar, Donya Naz, et al.
Publicado: (2020)

Bioinformatics and HIV Latency
por: Ciuffi, Angela, et al.
Publicado: (2015)

Diversity of small molecule HIV‐1 latency reversing agents identified in low‐ and high‐throughput small molecule screens
por: Hashemi, Pargol, et al.
Publicado: (2019)

Characterization of designed, synthetically accessible bryostatin analog HIV latency reversing agents
por: Marsden, Matthew D., et al.
Publicado: (2018)

HIV latency reversing agents act through Tat post translational modifications
por: Khoury, Georges, et al.
Publicado: (2018)

Benzolactam-related compounds promote apoptosis of HIV-infected human cells via protein kinase C–induced HIV latency reversal
por: Matsuda, Kouki, et al.
Publicado: (2019)

HIV-1 Latency and Latency Reversal: Does Subtype Matter?
por: Sarabia, Indra, et al.
Publicado: (2019)

Current Status of Latency Reversing Agents Facing the Heterogeneity of HIV-1 Cellular and Tissue Reservoirs
por: Ait-Ammar, Amina, et al.
Publicado: (2020)

Cross-species gene-family fluctuations reveal the dynamics of horizontal transfers
por: Grilli, Jacopo, et al.
Publicado: (2014)

New Concepts in Therapeutic Manipulation of HIV-1 Transcription and Latency: Latency Reversal versus Latency Prevention
por: Lewis, Catherine A., et al.
Publicado: (2023)

Diverse Impacts of HIV Latency-Reversing Agents on CD8+ T-Cell Function: Implications for HIV Cure
por: Clutton, Genevieve Tyndale, et al.
Publicado: (2018)

The BAF complex and HIV latency
por: Mahmoudi, Tokameh
Publicado: (2012)

HIV Latency-Reversing Agents Have Diverse Effects on Natural Killer Cell Function
por: Garrido, Carolina, et al.
Publicado: (2016)

Trade-off between synergy and efficacy in combinations of HIV-1 latency-reversing agents
por: Gupta, Vipul, et al.
Publicado: (2018)

Structure-Activity Relationship Analysis of Benzotriazine Analogues as HIV-1 Latency-Reversing Agents
por: Sorensen, Eric S., et al.
Publicado: (2020)

Latency reversal agents modulate HIV antigen processing and presentation to CD8 T cells
por: Boucau, Julie, et al.
Publicado: (2020)

Harmine enhances the activity of the HIV-1 latency-reversing agents ingenol A and SAHA
por: Taylor, Jared P., et al.
Publicado: (2020)

Discovering the Mechanisms of Oleodaphnone as a Potential HIV Latency-Reversing Agent by Transcriptome Profiling
por: Li, Shifei, et al.
Publicado: (2023)

Epigenetic Regulation of HIV-1 Sense and Antisense Transcription in Response to Latency-Reversing Agents
por: Li, Rui, et al.
Publicado: (2023)

The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation
por: Li, Zichong, et al.
Publicado: (2013)

Guanine radical chemistry reveals the effect of thermal fluctuations in gene promoter regions
por: Cuesta-López, Santiago, et al.
Publicado: (2011)

Opioid use does not limit potent low-dose HIV-1 latency reversal agent boosting
por: Lilie, Tyler, et al.
Publicado: (2023)

A modular CRISPR screen identifies individual and combination pathways contributing to HIV-1 latency
por: Hsieh, Emily, et al.
Publicado: (2023)

CRISPR-based gene knockout screens reveal deubiquitinases involved in HIV-1 latency in two Jurkat cell models
por: Rathore, Anurag, et al.
Publicado: (2020)

Innate immune regulation in HIV latency models
por: Olson, Rebecca M., et al.
Publicado: (2022)

A CRISPR Screen of HIV Dependency Factors Reveals That CCNT1 Is Non-Essential in T Cells but Required for HIV-1 Reactivation from Latency
por: Hafer, Terry L., et al.
Publicado: (2023)

A CRISPR screen of HIV dependency factors reveals CCNT1 is non-essential in T cells but required for HIV-1 reactivation from latency
por: Hafer, Terry L, et al.
Publicado: (2023)

Inconsistent reversal of HIV-1 latency ex vivo by antigens of HIV-1, CMV, and other infectious agents
por: Vollbrecht, Thomas, et al.
Publicado: (2020)

Editorial: The relevance of molecular mechanisms in HIV-1 latency and reactivation from latency
por: Pasternak, Alexander O., et al.
Publicado: (2023)

The differential short- and long-term effects of HIV-1 latency-reversing agents on T cell function
por: Clutton, G., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_in9m2acrt62nb8649d6e63ejil